HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma
HIST1H2BJ was identified as a critical gene associated with glioma prognosis and established as an independent prognostic factor for glioma patient survival and a candidate prognostic biomarker whose therapeutic relevance requires further functional and preclinical investigation.